ibandronic acid has been researched along with Renal Insufficiency in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (62.50) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bergner, R; Gretz, N; Kränzlin, B; Pohlmeyer-Esch, G; Siegrist, B | 1 |
| Antràs, L; Diel, IJ; Duh, MS; Green, J; Köppler, H; Neary, M; Smith, M; Weide, R; Wintfeld, N | 1 |
| Grieve, RJ; Hamilton, E; Hickish, T; Houston, S; Percival, F | 1 |
| Abadie-Lacourtoisie, S; Dür, C; Frimat, L; Lefeuvre, C; Letessier, S; Lortholary, A; Mefti-Lacheraf, F; Morvan, P; Pivot, X; Pujade-Lauraine, E | 1 |
| Bauss, F; Brkovic, D; Jakse, G; Linke, J | 1 |
| Jackson, GH | 1 |
| Bergner, R; Henrich, DM; Hoffmann, M; Honecker, A; Mikus, G; Nagel, D; Nauth, B; Uppenkamp, M | 1 |
| Civitelli, R; Emkey, R; Strampel, W | 1 |
2 review(s) available for ibandronic acid and Renal Insufficiency
| Article | Year |
|---|---|
Renal safety of ibandronate.
Topics: Bone Density Conservation Agents; Bone Neoplasms; Clinical Trials as Topic; Diphosphonates; Dose-Response Relationship, Drug; Humans; Ibandronic Acid; Kidney; Multiple Myeloma; Renal Insufficiency; Urologic Neoplasms | 2005 |
Safety considerations with bisphosphonates for the treatment of osteoporosis.
Topics: Acute-Phase Reaction; Administration, Oral; Alendronate; Bone Density Conservation Agents; Diphosphonates; Etidronic Acid; Female; Gastrointestinal Diseases; Humans; Ibandronic Acid; Injections, Intravenous; Jaw Diseases; Osteonecrosis; Osteoporosis, Postmenopausal; Renal Insufficiency; Risedronic Acid | 2007 |
2 trial(s) available for ibandronic acid and Renal Insufficiency
| Article | Year |
|---|---|
Renal safety of ibandronate 6 mg infused over 15 min versus 60 min in breast cancer patients with bone metastases: a randomized open-label equivalence trial.
Topics: Adult; Aged; Aged, 80 and over; Bone Density Conservation Agents; Bone Neoplasms; Breast Neoplasms; Diphosphonates; Drug Administration Schedule; Female; Humans; Ibandronic Acid; Infusions, Intravenous; Middle Aged; Renal Insufficiency; Treatment Outcome | 2011 |
Renal safety and pharmacokinetics of ibandronate in multiple myeloma patients with or without impaired renal function.
Topics: Adult; Aged; Aged, 80 and over; Bone Density Conservation Agents; Bone Diseases; Diphosphonates; Female; Humans; Ibandronic Acid; Infusions, Intravenous; Male; Middle Aged; Multiple Myeloma; Renal Insufficiency | 2007 |
4 other study(ies) available for ibandronic acid and Renal Insufficiency
| Article | Year |
|---|---|
Nephrotoxicity of ibandronate and zoledronate in Wistar rats with normal renal function and after unilateral nephrectomy.
Topics: Animals; Bone Density Conservation Agents; Diphosphonates; Female; Humans; Ibandronic Acid; Imidazoles; Kidney; Nephrectomy; Rats; Rats, Wistar; Renal Insufficiency; Zoledronic Acid | 2015 |
Risk of renal impairment after treatment with ibandronate versus zoledronic acid: a retrospective medical records review.
Topics: Adult; Aged; Aged, 80 and over; Bone Density Conservation Agents; Bone Neoplasms; Cancer Care Facilities; Creatinine; Diphosphonates; Female; Humans; Ibandronic Acid; Imidazoles; Male; Middle Aged; Multivariate Analysis; Neoplasms; Proportional Hazards Models; Renal Insufficiency; Retrospective Studies; Zoledronic Acid | 2009 |
Renal function changes and NHS resource use in breast cancer patients with metastatic bone disease treated with IV zoledronic acid or oral ibandronic acid: a four-centre non-interventional study.
Topics: Administration, Oral; Bone Density Conservation Agents; Bone Neoplasms; Breast Neoplasms; Diphosphonates; Female; Health Care Costs; Health Resources; Humans; Ibandronic Acid; Imidazoles; Infusions, Intravenous; Kidney; Kidney Function Tests; Middle Aged; Renal Insufficiency; State Medicine; Zoledronic Acid | 2010 |
Changes in bone structure after augmentation cystoplasty in chronic uraemic rats.
Topics: Animals; Bone Density; Bone Resorption; Chronic Disease; Diphosphonates; Female; Ibandronic Acid; Rats; Rats, Sprague-Dawley; Renal Insufficiency; Uremia; Urinary Diversion | 2005 |